Uchiyama M, Sakai K
J Int Med Res. 1985;13(1):54-8. doi: 10.1177/030006058501300108.
Na and K metabolism, and orthostatic response of blood pressure and plasma renin activity (PRA) were studied in six children, aged 10 to 15 years, with postural hypotension before and after treatment with Dihydergot (DHE). All abnormal findings which we had already observed in children with postural hypotension (i.e. low fractional excretion of filtered Na in spite of low PRA, extremely high PRA on fainting, great postural fall in blood pressure, and so on) improved on treatment with DHE. This suggests that these abnormal physiological findings found in children with postural hypotension may result from increased venous pooling which can be reduced by DHE. Consequently, DHE seems an excellent drug to treat postural hypotension from the physiological point of view.
对6名年龄在10至15岁、患有体位性低血压的儿童,在使用双氢麦角胺(DHE)治疗前后,研究了钠和钾代谢以及血压和血浆肾素活性(PRA)的直立位反应。我们在体位性低血压儿童中已经观察到的所有异常发现(即尽管PRA较低但滤过钠的分数排泄仍较低、晕厥时PRA极高、血压在体位改变时大幅下降等)在使用DHE治疗后均有所改善。这表明体位性低血压儿童中发现的这些异常生理发现可能是由于静脉池增加所致,而DHE可以减少这种增加。因此,从生理学角度来看,DHE似乎是治疗体位性低血压的一种极好药物。